Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval

Journal of Urology

Volumn 177, Issue 6, 2007, Pages 2081-2087

  Klatte, Tobias ^a   Patard, Jean Jacques ^b   Wunderlich, Heiko ^j   Goel, Rakhee H ^a   Lam, John S ^a   Junker, Kerstin ^j   Schubert, Jörg ^j   Böhm, Malte ^k   Allhoff, Ernst P ^k   Kabbinavar, Fairooz F ^a   Crepel, Maxime ^b   Cindolo, Luca ^l   De La Taille, Alexandre ^c   Tostain, Jacques ^d   Mejean, Arnaud ^e   Soulie, Michel ^f   Bellec, Laurent ^f   Bernhard, Jean Christophe ^g   Ferriere, Jean Marie ^g   Pfister, Christian ^h   Albouy, Baptiste ^h   Colombel, Marc ⁱ   Zisman, Amnon ^m   Belldegrun, Arie S ^a   Pantuck, Allan J ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ DE RENNES 1   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITÉ JEAN MONNET   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f UNIVERSITÉ DE TOULOUSE   (France)

^g UNIVERSITÉ DE BORDEAUX   (France)

^h UNIVERSITÉ DE ROUEN   (France)

ⁱ UNIVERSITÉ DE LYON   (France)

^j FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^k OTTO VON GUERICKE UNIVERSITY   (Germany)

^l UNIVERSITY OF SANNIO   (Italy)

^m TEL AVIV UNIVERSITY   (Israel)

more..

Author keywords

carcinoma; kidney; neoplasms; prognosis; renal cell; risk; second primary

Indexed keywords

ADOLESCENT; AGED; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; UNIVARIATE ANALYSIS; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHILD; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34248153169     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.01.122     Document Type: Article

References (18)

1. Grimaldi G., Reuter V., and Russo P. Bilateral non-familial renal cell carcinoma. Ann Surg Oncol 5 (1998) 548
2. Siemer S., Uder M., Zell A., Pönicke C., Humke U., Ziegler M., et al. Bilateral kidney tumor. Therapy management and histopathological results with long-term follow-up of 66 patients. Urologe A 40 (2001) 114
3. Hwang J.J., Uchio E.M., Pavlovich C.P., Pautler S.E., Libutti S.K., Linehan W.M., et al. Surgical management of multi-organ visceral tumors in patients with von Hippel-Lindau disease: a single stage approach. J Urol 169 (2003) 895
4. Farrow G. Diseases of the kidney. In: Murphy W.M. (Ed). Urological Pathology (1997), WB Saunders Co, Philadelphia 464-470
5. Zincke H., and Swanson S.K. Bilateral renal cell carcinoma: influence of synchronous and asynchronous occurrence on patient survival. J Urol 128 (1982) 913
6. Janzen N.K., Kim H.L., Figlin R.A., and Belldegrun A.S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 30 (2003) 843
7. Smith R.B., DeKernion J.B., Ehrlich R.M., Skinner D.G., and Kaufman J.J. Bilateral renal cell carcinoma and renal cell carcinoma in the solitary kidney. J Urol 132 (1984) 450
8. Heron D.E., Komarnicky L.T., Hyslop T., Schwartz G.F., and Mansfield C.M. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 88 (2000) 2739
9. Paulino A.C., Thakkar B., and Henderson W.G. Metachronous bilateral Wilms' tumor: the importance of time interval to the development of a second tumor. Cancer 82 (1998) 415
10. National Cancer Institute: Surveillance, Epidemiology and End Results (SEER). Available at http://seer.cancer.gov. Accessed December 9, 2006.
11. Wunderlich H., Schlichter A., Zermann D., Reichelt O., Kosmehl H., and Schubert J. Multifocality in renal cell carcinoma: a bilateral event?. Urol Int 63 (1999) 160
12. Blute M.L., Itano N.B., Cheville J.C., Weaver A.L., Lohse C.M., and Zincke H. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol 169 (2003) 1276
13. Brusky J.P., Gailani F., Pathak A., Patel H., and Aboseif S. High-dose interleukin-2 immunotherapy is safe for patients with metastatic renal cell carcinoma on dialysis. BJU Int 97 (2006) 279
14. Elson P.J., Witte R.S., and Trump D.L. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48 (1988) 7310
15. Hyman R.A., Voges V., and Finby N. Bilateral hypernephroma. Am J Roentgenol Radium Ther Nucl Med 117 (1973) 104
16. Kume H., Oda H., Nakatsuru Y., Shimizu Y., Takahashi Y., Matsumoto T., et al. Genetic identification of bilateral primary or metastatic nonpapillary renal cell carcinoma. BJU Int 86 (2000) 208
17. Kito H., Suzuki H., Igarashi T., Tobe T., Mizoguchi K., Kamiya N., et al. Distinct patterns of chromosomal losses in clinically synchronous and asynchronous bilateral renal cell carcinoma. J Urol 168 (2002) 2637
18. Weaver D.J., Michalski K., and Miles J.H. Cytogenetics of bilateral renal cell carcinoma. J Urol 142 (1989) 697